Procyon Advisors, LLC Invitae Corp Transaction History

Procyon Advisors, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 11, 2022	SELL	$2.13 - $9.01 $7,286 - $30,823	-3,421 Reduced 12.22%	24,567 $60,000
Q1 2022 Apr 18, 2022	BUY	$6.28 - $15.59 $175,764 - $436,332	27,988 New	27,988 $223,000
Q4 2021 Jan 18, 2022	SELL	$14.7 - $28.67 $149,116 - $290,828	-10,144 Closed	0 $0
Q3 2021 Oct 14, 2021	BUY	$24.31 - $33.6 $15,777 - $21,806	649 Added 6.84%	10,144 $288,000
Q2 2021 Jul 22, 2021	BUY	$26.09 - $40.4 $30,238 - $46,823	1,159 Added 13.9%	9,495 $320,000

Q1 2021 Apr 29, 2021	BUY	$33.06 - $56.93 $60,036 - $103,384	1,816 Added 27.85%	8,336 $319,000
Q4 2020 Jan 19, 2021	BUY	$39.09 - $57.4 $38,269 - $56,194	979 Added 17.67%	6,520 $273,000
Q3 2020 Oct 22, 2020	BUY	$28.43 - $44.67 $170 - $268	6 Added 0.11%	5,541 $240,000
Q2 2020 Aug 14, 2020	BUY	$11.71 - $30.29 $64,814 - $167,655	5,535 New	5,535 $168,000

7.66M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of Procyon Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Procyon Advisors, LLC with notifications on news.